Portal Instruments is a clinical stage, privately funded, medical device company focused on advanced drug delivery and solving the challenge of self-administering biological medicines.

We are developing and commercializing a highly innovative needle-free jet injection platform licensed from MIT, that transforms the drug delivery experience for patients suffering from chronic disease. Our aim is to replace all needles and syringes with a safe, fast, and connected device and to become the standard for modern drug delivery. The device is easy to use and its digital health features empower the patient to holistically manage their chronic condition interactively.



At Portal we believe that patients deserve more than a 160 year old technology, the needle & syringe

Our Vision is a Needle Free World

Our Mission is to improve the experience for patients on life-changing therapies



  • We can make a significant contribution to patients’ lives by bringing to market innovative, creative, and disruptive ideas in the field of drug delivery

  • We hold ourselves to the highest standards of honesty, integrity, and intellectual rigor

  • We realize that it will take an amazing and diverse team to fulfill our mission and value teamwork, collegiality, transparency and inclusion

  • We can only expand our organization by continuously teaching and growing our people

  • We are relentless about finding clear solutions to real problems efficiently

  • We are results-driven and will do what it takes to get it done

  • We partner with pharma companies to improve and enable their life-changing therapies and are the easiest, smartest company to partner with



To build a needle-free drug delivery system
that is transformative, interactive, and easy to use, and
to go to market with pharmaceutical partners who develop life-changing biological proteins that treat chronic diseases.



Portal has assembled a team of passionate leaders from the medical device industry bringing together their collective experiences of medical device development and commercialization.

Sunrise is a Sanofi initiative that connects world-class science and emerging platforms with committed resources and expert capabilities from Sanofi. Our aim is to turn basic scientific discoveries from outstanding scientists and clinicians into new medicines and treatment paradigms for patients in need.

5AM Ventures is a leading venture capital firm focused on building next-generation life science companies capable of delivering outstanding returns to our investors. 5AM’s investment professionals possess strong scientific, medical, operational, legal and finance expertise.

Takeda Pharmaceutical Company Limited is a global, research and development-driven pharmaceutical company committed to bringing better health and a brighter future to patients by translating science into life-changing medicines. Takeda focuses its R&D efforts on oncology, gastroenterology and central nervous system therapeutic areas plus vaccines. Takeda conducts R&D both internally and with partners to stay at the leading edge of innovation. New innovative products, especially in oncology and gastroenterology, as well as our presence in Emerging Markets, fuel the growth of Takeda. More than 30,000 Takeda employees are committed to improving quality of life for patients, working with our partners in health care in more than 70 countries. For more information, visit http://www.takeda.com/news.

Pages of the Portal Instruments website may contain links to third party websites that are not under the control of Portal Instruments. Portal Instruments is not responsible for the content of any such site and the inclusion of these links does not imply the endorsement of the content of the linked site by Portal Instruments.